JNCI Journal of the National Cancer Institute

IN THIS ISSUE

IN THIS ISSUE
J. Natl. Cancer Inst. 2005 97: 1167; doi:10.1093/jnci/dji282 [Extract] [Full Text] [PDF] [Japanese Translation]  

MEMO TO THE MEDIA

Elana Hayasaka

Press Release: Gefitinib and Cetuximab Have Same Target, Different Responses for Lung Cancer Patients with Specific Genetic Mutation
J. Natl. Cancer Inst. 2005 97: 1167; doi:10.1093/jnci/dji287 [Extract] [Full Text]  

EDITORIALS

John D. Minna, Michael J. Peyton, and Adi F. Gazdar

Gefitinib Versus Cetuximab in Lung Cancer: Round One
J. Natl. Cancer Inst. 2005 97: 1168-1169; doi:10.1093/jnci/dji247 [Extract] [Full Text] [PDF]  

Monika K. Krzyzanowska and Ian F. Tannock

Should Screen-detected Breast Cancers Be Managed Differently?
J. Natl. Cancer Inst. 2005 97: 1170-1171; doi:10.1093/jnci/dji246 [Extract] [Full Text] [PDF]  

NEWS

Sarah L. Zielinski

Following Positive Epidemiologic Studies, Statins to Enter Clinical Trials for Cancer Prevention
J. Natl. Cancer Inst. 2005 97: 1172-1173; doi:10.1093/jnci/dji267 [Extract] [Full Text] [PDF]  

Rabiya S. Tuma

Efforts Aimed at Reducing Noise, Data Overload in Microarrays
J. Natl. Cancer Inst. 2005 97: 1173-1175; doi:10.1093/jnci/dji268 [Extract] [Full Text] [PDF]  

Vicki Brower

Researchers Attempting To Define Role of Cytokines in Cancer Risk
J. Natl. Cancer Inst. 2005 97: 1175-1177; doi:10.1093/jnci/dji269 [Extract] [Full Text] [PDF]  

Elana Hayasaka and Sarah L. Zielinski

In Brief
J. Natl. Cancer Inst. 2005 97: 1177; doi:10.1093/jnci/dji271 [Extract] [Full Text] [PDF]  

Stat Bite: Average Length of Hospital Stay by Diagnostic Category, 2003
J. Natl. Cancer Inst. 2005 97: 1178; doi:10.1093/jnci/dji266 [Extract] [Full Text] [PDF]  

Brian Vastag

Near-Final Word on Adjuvant Chemotherapy for Breast Cancer Is Good News
J. Natl. Cancer Inst. 2005 97: 1178-1179; doi:10.1093/jnci/dji270 [Extract] [Full Text] [PDF]  

Awards, Appointments, Announcements
J. Natl. Cancer Inst. 2005 97: 1179; doi:10.1093/jnci/dji272 [Extract] [Full Text] [PDF]  

COMMENTARY

Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei, Sheila E. Taube, Massimo Gion, and Gary M. Clark for the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
J. Natl. Cancer Inst. 2005 97: 1180-1184; doi:10.1093/jnci/dji237 [Abstract] [Full Text] [PDF]  

ARTICLES

Toru Mukohara, Jeffrey A. Engelman, Nasser H. Hanna, Beow Y. Yeap, Susumu Kobayashi, Neal Lindeman, Balázs Halmos, Joseph Pearlberg, Zenta Tsuchihashi, Lewis C. Cantley, Daniel G. Tenen, Bruce E. Johnson, and Pasi A. Jänne

Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations
J. Natl. Cancer Inst. 2005 97: 1185-1194; doi:10.1093/jnci/dji238 [Abstract] [Full Text] [PDF]  

Yu Shen, Ying Yang, Lurdes Y. T. Inoue, Mark F. Munsell, Anthony B. Miller, and Donald A. Berry

Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials
J. Natl. Cancer Inst. 2005 97: 1195-1203; doi:10.1093/jnci/dji239 [Abstract] [Full Text] [PDF]  

Anthony J. Swerdlow, Minouk J. Schoemaker, Craig D. Higgins, Alan F. Wright, and Patricia A. Jacobs on behalf of the UK Clinical Cytogenetics Group

Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study
J. Natl. Cancer Inst. 2005 97: 1204-1210; doi:10.1093/jnci/dji240 [Abstract] [Full Text] [PDF]  

Laura-Mae Baldwin, Sharon A. Dobie, Kevin Billingsley, Yong Cai, George E. Wright, Jason A. Dominitz, William Barlow, Joan L. Warren, and Stephen H. Taplin

Explaining Black–White Differences in Receipt of Recommended Colon Cancer Treatment
J. Natl. Cancer Inst. 2005 97: 1211-1220; doi:10.1093/jnci/dji241 [Abstract] [Full Text] [PDF] [Supplementary Table]  

BRIEF COMMUNICATION

Deborah Schrag, Ki Young Chung, Carlos Flombaum, and Leonard Saltz

Cetuximab Therapy and Symptomatic Hypomagnesemia
J. Natl. Cancer Inst. 2005 97: 1221-1224; doi:10.1093/jnci/dji242 [Abstract] [Full Text] [PDF]  

CORRESPONDENCE

Ann F. Chambers

Re: Medroxyprogesterone Acetate and Metastases: Of Mice and (Wo)Men
J. Natl. Cancer Inst. 2005 97: 1225; doi:10.1093/jnci/dji233 [Extract] [Full Text] [PDF]  

V. Craig Jordan

RESPONSE: Re: Medroxyprogesterone Acetate and Metastases: Of Mice and (Wo)Men
J. Natl. Cancer Inst. 2005 97: 1225-1226; doi:10.1093/jnci/dji234 [Extract] [Full Text] [PDF]  

Ronghui Xu and Anthony Gamst

Re: Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics
J. Natl. Cancer Inst. 2005 97: 1226; doi:10.1093/jnci/dji235 [Extract] [Full Text] [PDF]  

David F. Ransohoff

RESPONSE: Re: Lessons from Controversy: Ovarian Cancer Screening and Serum Proteomics
J. Natl. Cancer Inst. 2005 97: 1227; doi:10.1093/jnci/dji236 [Extract] [Full Text] [PDF]  

Erratum
J. Natl. Cancer Inst. 2005 97: 1227; doi:10.1093/jnci/dji284 [Extract] [Full Text] [PDF]  

ONLINE COMMENTARY

Thilo Kober, Nicole Skoetz, Sven Trelle, Julia Bohlius, and Andreas Engert

Third Biannual Report of the Cochrane Haematological Malignancies Group
J. Natl. Cancer Inst. 2005 97: E2; doi:10.1093/jnci/dji258 [Extract] [Full Text]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.